SEVERE CARDIOMYOPATHY SECONDARY TO ANTI-TNF THERAPY FOR CROHN’S DISEASE

@inproceedings{Rezik2016SEVERECS,
  title={SEVERE CARDIOMYOPATHY SECONDARY TO ANTI-TNF THERAPY FOR CROHN’S DISEASE},
  author={Mohamed Rezik and Deirdre Mattina},
  year={2016}
}
Tumor necrosis factor-alpha inhibitors are a popular and effective therapy for inflammatory bowel disease and other inflammatory conditions. Despite a substantial amount of evidence, cardiomyopathy is a widely unrecognized adverse effect of these medications. A 57-year-old male presented with a two